Roper Technologies (ROP) is down 3.6% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be a post-earnings “sell-the-news” reaction after Roper reported Q1 results and raised full-year profit guidance on April 23, 2026. With the headline numbers already out and the stock having moved higher around the release, some investors may be taking profits while the market refocuses on margin trends and the path for organic growth.
Details:
Sources:
Roper Technologies (press release), Investing.com, MarketBeat
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ROP Insider Trading Activity
$ROP insiders have traded $ROP stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ROP stock by insiders over the last 6 months:
- LAURENCE NEIL HUNN (President and CEO) has made 2 purchases buying 10,000 shares for an estimated $4,522,310 and 7 sales selling 30,000 shares for an estimated $13,307,176.
- JASON CONLEY (EVP, Chief Financial Officer) sold 6,000 shares for an estimated $2,673,390
- AMY WOODS BRINKLEY purchased 1,200 shares for an estimated $540,855
- THOMAS PATRICK JR JOYCE purchased 1,400 shares for an estimated $501,844
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$ROP Hedge Fund Activity
We have seen 493 institutional investors add shares of $ROP stock to their portfolio, and 725 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 3,190,548 shares (+3315.1%) to their portfolio in Q4 2025, for an estimated $1,420,208,631
- WINDACRE PARTNERSHIP LLC added 3,096,100 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,378,166,993
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,916,800 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $1,298,355,184
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,249,991 shares (-77.7%) from their portfolio in Q4 2025, for an estimated $1,001,538,493
- VANGUARD GROUP INC added 1,384,656 shares (+12.5%) to their portfolio in Q4 2025, for an estimated $616,351,925
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,337,272 shares (-43.5%) from their portfolio in Q4 2025, for an estimated $595,259,885
- JPMORGAN CHASE & CO added 1,057,511 shares (+66.7%) to their portfolio in Q4 2025, for an estimated $470,729,871
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$ROP Government Contracts
We have seen $22,401,318 of award payments to $ROP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- DECISION SUPPORT SOFTWARE MAINTENANCE AND SUPPORT: $3,531,932
- VANEC VISNS 1,2,4,5: $2,220,643
- UNIVERSAL LABORATORY INTERFACE MAINTENANCE - DATA INNOVATIONS INSTRUMENT MANAGEMENT VISN 12: $1,555,291
- THE ORDER PROVIDES FOR DATA INNOVATIONS INSTRUMENT MANAGER SOFTWARE LICENSES, SUSTAINMENT, AND CONSULTING S...: $1,400,482
- EXPRESS REPORT: NX ORDERS PLACED FOR THE MONTH OF JUNE 2025: $1,036,733
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ROP Congressional Stock Trading
Members of Congress have traded $ROP stock 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ROP stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 03/13, 02/10.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 02/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$ROP Analyst Ratings
Wall Street analysts have issued reports on $ROP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/28/2026
- Barclays issued a "Underweight" rating on 01/28/2026
- Citigroup issued a "Buy" rating on 01/28/2026
- Mizuho issued a "Underperform" rating on 01/28/2026
- JP Morgan issued a "Underweight" rating on 01/28/2026
- Piper Sandler issued a "Overweight" rating on 11/20/2025
To track analyst ratings and price targets for $ROP, check out Quiver Quantitative's $ROP forecast page.
$ROP Price Targets
Multiple analysts have issued price targets for $ROP recently. We have seen 13 analysts offer price targets for $ROP in the last 6 months, with a median target of $450.0.
Here are some recent targets:
- Clarke Jeffries from Piper Sandler set a target price of $540.0 on 04/24/2026
- Deane Dray from RBC Capital set a target price of $407.0 on 04/24/2026
- Jon Vruwink from Baird set a target price of $470.0 on 04/24/2026
- Julian Mitchell from Barclays set a target price of $380.0 on 04/01/2026
- Joe Ritchie from Goldman Sachs set a target price of $440.0 on 01/29/2026
- Brad Reback from Stifel set a target price of $385.0 on 01/28/2026
- Brett Linzey from Mizuho set a target price of $365.0 on 01/28/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.